Yuang Chen

6PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2026
MYC-bound enhancer RNAs in cis regulate gene transcription and tumorigenesis.

|Aug 12, 2025
The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition.

Dhamotharan Pattarayan, Yue Wang, Zehua Wang

|May 05, 2025
Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance.

Haozhe Huang, Yiqing Mu, Yixian Huang

|Jan 04, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.

Zhangyi Luo, Yixian Huang, Neelu Batra

|Dec 08, 2022
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response.

Yifei Wang, Yueshan Zhao, Weiwei Guo

|Nov 24, 2022
Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy.

Yuang Chen, Yixian Huang, Qinzhe Li

Pageof 1

Frequent Collaborators

6 joint publications

Song Li

5 joint publications

Da Yang

4 joint publications

Yifei Wang

3 joint publications

Ziqian Zhang